Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers

Identifieur interne : 002498 ( Main/Exploration ); précédent : 002497; suivant : 002499

Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers

Auteurs : N. Yamane [Japon] ; Y. Nakamura [Japon] ; M. Yuki [Japon] ; T. Odagiri [Japon] ; N. Ishida [Japon]

Source :

RBID : ISTEX:3B333BD65FEFD81BE595B8FDD2B3DFD2B68933FB

Descripteurs français

English descriptors

Abstract

A cold-adapted influenza A virus, CR-37 (H1N1), derived from genetic reassortment between A/Ann Arbor/6/60 (H2N2) cold-adapted variant virus and A/California/10/78 (H1N1) wild-type virus, was tested in Japanese adult volunteers. The CR-37 live virus preparation induced only low-grade clinical reactionsin volunteers for the first 3–4 days after inoculation. Two vaccinees who did not show any antibody changes became febrile (over 38–0 °C). Skin tests using the vaccine preparation and uninfected allantoic fluid were performed, and indicated that one of these two vaccinees was positive for the CR-37 vaccine preparation. A high proportion of the vaccinees whose sera had a haemagglutination-inhibition (HI) antibody titre against thevaccine strain of ≤ 64 before inoculation, seroconverted in both HI and neuraminidase-inhibition (NA1) antibody titrations, and only a few seroconverted in the titration of antibody against type-specific internal antigens. The serological examinations against heterotypic H1N1 variants indicated that the cold-adapted live influenza virus vaccine could induce a broad spectrum of HI antibody reactivity and immunity of long duration.

Url:
DOI: 10.1017/S0022172400064251


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers</title>
<author>
<name sortKey="Yamane, N" sort="Yamane, N" uniqKey="Yamane N" first="N." last="Yamane">N. Yamane</name>
</author>
<author>
<name sortKey="Nakamura, Y" sort="Nakamura, Y" uniqKey="Nakamura Y" first="Y." last="Nakamura">Y. Nakamura</name>
</author>
<author>
<name sortKey="Yuki, M" sort="Yuki, M" uniqKey="Yuki M" first="M." last="Yuki">M. Yuki</name>
</author>
<author>
<name sortKey="Odagiri, T" sort="Odagiri, T" uniqKey="Odagiri T" first="T." last="Odagiri">T. Odagiri</name>
</author>
<author>
<name sortKey="Ishida, N" sort="Ishida, N" uniqKey="Ishida N" first="N." last="Ishida">N. Ishida</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3B333BD65FEFD81BE595B8FDD2B3DFD2B68933FB</idno>
<date when="1984" year="1984">1984</date>
<idno type="doi">10.1017/S0022172400064251</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6GQ-NQ1KPZ7X-M/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000168</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000168</idno>
<idno type="wicri:Area/Istex/Curation">000168</idno>
<idno type="wicri:Area/Istex/Checkpoint">001168</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001168</idno>
<idno type="wicri:doubleKey">0022-1724:1984:Yamane N:serological:evaluation:of</idno>
<idno type="wicri:Area/Main/Merge">002624</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:6707472</idno>
<idno type="wicri:Area/PubMed/Corpus">000523</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000523</idno>
<idno type="wicri:Area/PubMed/Curation">000523</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000523</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000457</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000457</idno>
<idno type="wicri:Area/Ncbi/Merge">001215</idno>
<idno type="wicri:Area/Ncbi/Curation">001215</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001215</idno>
<idno type="wicri:doubleKey">0022-1724:1984:Yamane N:serological:evaluation:of</idno>
<idno type="wicri:Area/Main/Merge">002610</idno>
<idno type="wicri:Area/Main/Curation">002498</idno>
<idno type="wicri:Area/Main/Exploration">002498</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers</title>
<author>
<name sortKey="Yamane, N" sort="Yamane, N" uniqKey="Yamane N" first="N." last="Yamane">N. Yamane</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Clinical Microbiology Branch, Central Clinical Laboratory, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980</wicri:regionArea>
<wicri:noRegion>Sendai 980</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Present address: Department of laboratory Medicine, Kumamoto University Medical School, 1-1-1, Honjo, Kumamoto 860</wicri:regionArea>
<wicri:noRegion>Kumamoto 860</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nakamura, Y" sort="Nakamura, Y" uniqKey="Nakamura Y" first="Y." last="Nakamura">Y. Nakamura</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Clinical Microbiology Branch, Central Clinical Laboratory, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980</wicri:regionArea>
<wicri:noRegion>Sendai 980</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yuki, M" sort="Yuki, M" uniqKey="Yuki M" first="M." last="Yuki">M. Yuki</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Clinical Microbiology Branch, Central Clinical Laboratory, Tohoku University School of Medicine, 1-1 Seiryo-machi, Sendai 980</wicri:regionArea>
<wicri:noRegion>Sendai 980</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Odagiri, T" sort="Odagiri, T" uniqKey="Odagiri T" first="T." last="Odagiri">T. Odagiri</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Bacteriology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Sendai 980</wicri:regionArea>
<wicri:noRegion>Sendai 980</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ishida, N" sort="Ishida, N" uniqKey="Ishida N" first="N." last="Ishida">N. Ishida</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Bacteriology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Sendai 980</wicri:regionArea>
<wicri:noRegion>Sendai 980</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Hygiene</title>
<title level="j" type="abbrev">J. Hyg.</title>
<idno type="ISSN">0022-1724</idno>
<imprint>
<publisher>Cambridge University Press</publisher>
<pubPlace>Cambridge, UK</pubPlace>
<date type="published" when="1984-04">1984-04</date>
<biblScope unit="volume">92</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="231">231</biblScope>
<biblScope unit="page" to="242">242</biblScope>
</imprint>
<idno type="ISSN">0022-1724</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0022-1724</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Antibodies, Viral (analysis)</term>
<term>Antigens, Viral (immunology)</term>
<term>Complement Fixation Tests</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Hemagglutinins, Viral (immunology)</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Intradermal Tests</term>
<term>Japan</term>
<term>Neuraminidase (immunology)</term>
<term>Pharynx (immunology)</term>
<term>Time Factors</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Anticorps antiviraux (analyse)</term>
<term>Antigènes viraux (immunologie)</term>
<term>Facteurs temps</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (immunologie)</term>
<term>Humains</term>
<term>Hémagglutinines virales (immunologie)</term>
<term>Japon</term>
<term>Pharynx (immunologie)</term>
<term>Sialidase (immunologie)</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Tests de fixation du complément</term>
<term>Tests intradermiques</term>
<term>Vaccination</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Virus de la grippe A (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Antigens, Viral</term>
<term>Hemagglutinins, Viral</term>
<term>Influenza Vaccines</term>
<term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Japan</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Antigènes viraux</term>
<term>Grippe humaine</term>
<term>Hémagglutinines virales</term>
<term>Pharynx</term>
<term>Sialidase</term>
<term>Vaccins antigrippaux</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Influenza A virus</term>
<term>Influenza, Human</term>
<term>Pharynx</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Complement Fixation Tests</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Intradermal Tests</term>
<term>Time Factors</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Facteurs temps</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Japon</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Tests de fixation du complément</term>
<term>Tests intradermiques</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Japon</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">A cold-adapted influenza A virus, CR-37 (H1N1), derived from genetic reassortment between A/Ann Arbor/6/60 (H2N2) cold-adapted variant virus and A/California/10/78 (H1N1) wild-type virus, was tested in Japanese adult volunteers. The CR-37 live virus preparation induced only low-grade clinical reactionsin volunteers for the first 3–4 days after inoculation. Two vaccinees who did not show any antibody changes became febrile (over 38–0 °C). Skin tests using the vaccine preparation and uninfected allantoic fluid were performed, and indicated that one of these two vaccinees was positive for the CR-37 vaccine preparation. A high proportion of the vaccinees whose sera had a haemagglutination-inhibition (HI) antibody titre against thevaccine strain of ≤ 64 before inoculation, seroconverted in both HI and neuraminidase-inhibition (NA1) antibody titrations, and only a few seroconverted in the titration of antibody against type-specific internal antigens. The serological examinations against heterotypic H1N1 variants indicated that the cold-adapted live influenza virus vaccine could induce a broad spectrum of HI antibody reactivity and immunity of long duration.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Japon</li>
</country>
</list>
<tree>
<country name="Japon">
<noRegion>
<name sortKey="Yamane, N" sort="Yamane, N" uniqKey="Yamane N" first="N." last="Yamane">N. Yamane</name>
</noRegion>
<name sortKey="Ishida, N" sort="Ishida, N" uniqKey="Ishida N" first="N." last="Ishida">N. Ishida</name>
<name sortKey="Nakamura, Y" sort="Nakamura, Y" uniqKey="Nakamura Y" first="Y." last="Nakamura">Y. Nakamura</name>
<name sortKey="Odagiri, T" sort="Odagiri, T" uniqKey="Odagiri T" first="T." last="Odagiri">T. Odagiri</name>
<name sortKey="Yamane, N" sort="Yamane, N" uniqKey="Yamane N" first="N." last="Yamane">N. Yamane</name>
<name sortKey="Yuki, M" sort="Yuki, M" uniqKey="Yuki M" first="M." last="Yuki">M. Yuki</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002498 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002498 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:3B333BD65FEFD81BE595B8FDD2B3DFD2B68933FB
   |texte=   Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021